Physiologically-based pharmacokinetic modelling of the 2-monthly regimen of long-acting injectable rilpivirine administered in pregnancy

被引：0
|
作者：
Atoyebi, Shakir [1 ]
Siccardi, Marco [1 ]
Waitt, Catriona [1 ]
机构：
[1] Univ Liverpool, Liverpool, England
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2023年 / 180卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P0643
引用
收藏
页码：338 / 340
页数：3
相关论文
共 50 条
  • [1] Physiologically-based pharmacokinetic modelling of long-acting injectable cabotegravir and rilpivirine in pregnancy
    Atoyebi, Shakir
    Bunglawala, Fazila
    Cottura, Nicolas
    Granana-Castillo, Sandra
    Montanha, Maiara Camotti
    Olagunju, Adeniyi
    Siccardi, Marco
    Waitt, Catriona
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024,
  • [2] Physiologically based pharmacokinetic modelling of long-acting rilpivirine in pregnancy
    Atoyebi, S.
    Granana-Castillo, S.
    Siccardi, M.
    Waitt, C.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 186 - 187
  • [3] Physiologically Based Pharmacokinetic Modelling to Inform Development of Intramuscular Long-Acting Nanoformulations for HIV
    Rajith K. R. Rajoli
    David J. Back
    Steve Rannard
    Caren L. Freel Meyers
    Charles Flexner
    Andrew Owen
    Marco Siccardi
    Clinical Pharmacokinetics, 2015, 54 : 639 - 650
  • [4] Physiologically Based Pharmacokinetic Modelling to Inform Development of Intramuscular Long-Acting Nanoformulations for HIV
    Rajoli, Rajith K. R.
    Back, David J.
    Rannard, Steve
    Meyers, Caren L. Freel
    Flexner, Charles
    Owen, Andrew
    Siccardi, Marco
    CLINICAL PHARMACOKINETICS, 2015, 54 (06) : 639 - 650
  • [5] Expanded Insights From a Case Study on Long-Acting Injectable Cabotegravir and Rilpivirine in Pregnancy
    Ziemba, Lauren
    Ketchum, Rachel
    Brummel, Sean
    CLINICAL INFECTIOUS DISEASES, 2025,
  • [6] Long-acting cabotegravir and rilpivirine for HIV-1 suppression: switch to 2-monthly dosing after 5 years of daily oral therapy
    Mills, Anthony
    Richmond, Gary J.
    Newman, Cheryl
    Osiyemi, Olayemi
    Cade, Jerry
    Brinson, Cynthia
    De Vente, Jerome
    Margolis, David A.
    Sutton, Kenneth C.
    Wilches, Viviana
    Hatch, Sarah
    Roberts, Jeremy
    McCoig, Cynthia
    Garris, Cindy
    Vandermeulen, Kati
    Spreen, William R.
    AIDS, 2022, 36 (02) : 195 - 203
  • [7] Predicting Drug-Drug Interactions Between Rifampicin and Long-Acting Cabotegravir and Rilpivirine Using Physiologically Based Pharmacokinetic Modeling
    Rajoli, Rajith K. R.
    Curley, Paul
    Chiong, Justin
    Back, David
    Flexner, Charles
    Owen, Andrew
    Siccardi, Marco
    JOURNAL OF INFECTIOUS DISEASES, 2019, 219 (11): : 1735 - 1742
  • [8] Cabotegravir-Rilpivirine: The First Complete Long-Acting Injectable Regimen for the Treatment of HIV-1 Infection
    Durham, Spencer H.
    Chahine, Elias B.
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (11) : 1397 - 1409
  • [9] Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
    Hannah Kinvig
    Nicolas Cottura
    Andrew Lloyd
    Collrane Frivold
    Jessica Mistilis
    Courtney Jarrahian
    Marco Siccardi
    European Journal of Drug Metabolism and Pharmacokinetics, 2022, 47 : 855 - 868
  • [10] Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
    Kinvig, Hannah
    Cottura, Nicolas
    Lloyd, Andrew
    Frivold, Collrane
    Mistilis, Jessica
    Jarrahian, Courtney
    Siccardi, Marco
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2022, 47 (06) : 855 - 868
12345